Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 26;15(2):74-76.
doi: 10.1002/cld.908. eCollection 2020 Feb.

Position 2: Transarterial Radioembolization Should Be the Primary Locoregional Therapy for Unresectable Hepatocellular Carcinoma

Syed Irfan-Ur Rahman  1 , Laura Nunez-Herrero  1 , Jamie Lee Berkes  2
Affiliations
Review

Position 2: Transarterial Radioembolization Should Be the Primary Locoregional Therapy for Unresectable Hepatocellular Carcinoma

Syed Irfan-Ur Rahman et al. Clin Liver Dis (Hoboken). .

Abstract

http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2046-2484/video/15-2-reading-rahman a video presentation of this article.

PubMed Disclaimer

References

    1. Petrick JL, Braunlin M, Laversanne M, et al. International trends in liver cancer incidence, overall and by histologic subtype, 1978‐2007. Int J Cancer 2016;139:1534‐1545. - PMC - PubMed
    1. Petrick JL, Kelly SP, Altekruse SF, et al. Future of hepatocellular carcinoma incidence in the United States forecast through 2030. J Clin Oncol 2016;34:1787‐1794. - PMC - PubMed
    1. Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2018;68:723‐750. - PubMed
    1. Casadei Gardini A, Tamburini E, Inarrairaegui M, et al. Radioembolization versus chemoembolization for unresectable hepatocellular carcinoma: A meta‐analysis of randomized trials. Onco Targets Ther 2018;11:7315‐7321. - PMC - PubMed
    1. Salem R, Lewandowski RJ, Kulik L, et al. Radioembolization results in longer time‐to‐progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 2011;140:497‐507.e2. - PMC - PubMed